Responses

Protocol
PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT): a prospective longitudinal study protocol investigating the prevalence, severity and determinants of atherosclerotic cardiovascular disease in the young adult Pakistani population
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Response regarding the PAK-SEHAT Longitudinal Study on Premature Coronary Atherosclerosis
    • Zunaira Kiran, Student Sindh Medical College
    • Other Contributors:
      • Umaimah Batool Mirza, Doctor
      • Imteshal Sarfaraz, Student

    The study protocol by Zaman et al describes PAK-SEHAT as the research initiative for investigating premature atherosclerotic cardiovascular disease (ASCVD) in Pakistan. The research targets an important knowledge gap in cardiovascular healthcare research for South Asia because its CVD prevalence continues to increase in populations with low-to-middle income status.

    Several comments arise from our reading of the research. The research identifies “young adults” as very mature males who are younger than 60 and very mature females who are younger than 65 years but this definition goes beyond the typical age range of 18–44 years [1]. The expanded population inclusion might dim the line separating early and conventional ASCVD manifestation.

    CCTA along with CIMT serves as an effective method to detect subclinical plaques in patients [2]. These expensive diagnostic tests represent a major barrier that affects the system-wide implementation of public health screening and intervention programs in Pakistan.

    Excluding participants with BMI higher than 40 kg/m² or eGFR lower than 60 ml/min/1.73m² may unintentionally exclude persons at high risk from the study. People with South Asian origins who have metabolic syndrome or renal impairment tend to develop ASCVD at an earlier stage according to research [3] and their removal from the study might diminish the application of study findings to wider populations.

    The protocol states it will recruit nationally in P...

    Show More
    Conflict of Interest:
    None declared.